Continuous Care Intervention in Primary Care to Improve Type 2 Diabetes Control in Terres de l'Ebre, Catalonia

Launched by INSTITUT INVESTIGACIO SANITARIA PERE VIRGILI · Aug 8, 2025

Keywords

ClinConnect Summary

This clinical trial is testing a new approach to help adults with type 2 diabetes better manage their condition in the Terres de l’Ebre region of Catalonia. The study focuses on improving diabetes care by training doctors and nurses in local primary care centers. This training is led by diabetes specialists and nurse educators and includes both classroom learning and practical guidance on the latest ways to treat diabetes. The goal is to see if this continuous support for healthcare professionals can help patients keep their blood sugar levels (measured by a test called HbA1c) under better control over time.

Adults who have had type 2 diabetes for at least one year and are receiving care in participating centers may be eligible to join. People with type 1 diabetes, those currently treated by a diabetes specialist, or with certain other health conditions are not included. If you take part, your usual doctor and nurse will receive extra training over one year, but your own care will continue as normal. The study will check your health at the start, 6 months, 12 months, and again after 2 years to see if this training helps improve diabetes control. All personal information collected will be kept confidential and anonymous.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Enrollment will begin in July 2025, aligned with the initiation of training sessions for healthcare professionals (physicians and nurses).
• Eligible participants must:
• • Be adults (≥18 years old)
• • Have an active diagnosis of T2DM documented in the eCAP primary care electronic health record system
• • Have a duration of T2DM of at least 12 months as of January 2025
• Exclusion Criteria:
• • Diagnosis of type 1 diabetes mellitus (T1DM)
• • T2DM managed by a specialist at the time of inclusion
• • Current treatment with systemic corticosteroids
• • Active neoplasia (malignancy)
• • Gestational diabetes
• • Pregnancy or breastfeeding
• • Diagnosis of MACA (advanced chronic disease with life expectancy \<1 year)
• • Complex chronic patients (CCP)
• • Diagnosis of dementia
• • Institutionalized patients or those residing in social healthcare facilities
• • Age over 90 years
• • Age under 18 years
• • Severe psychiatric illness (e.g., psychosis, bipolar disorder, major depression)
• • History of kidney transplant
• • Undergoing dialysis
• • History of alcohol or drug abuse